Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein-coupled receptor 3 (GPR3) is an orphan class A GPCR broadly expressed in the brain (hypothalamus, hippocampus, cortex) and peripheral tissues (liver, ovary)[1][5]. It is notable for its high constitutive activity, meaning it activates Gs proteins and elevates cAMP in the absence of a classical ligand. This intrinsic activity regulates diverse physiological functions, including neuronal growth, oocyte maturation, and adipose tissue thermogenesis[1][6][2]. GPR3 is implicated in Alzheimer’s disease, as it regulates γ-secretase activity and amyloid precursor protein processing, and is also involved in oocyte meiosis arrest and cold-induced adipose lipolysis[1][3][6]. Structural studies reveal a lipid-like molecule, possibly an endogenous lipid or fatty acid, binds within its hydrophobic orthosteric pocket, suggesting activation via a ubiquitous lipid ligand, although the precise endogenous ligand is still debated[1][5]. GPR3 operates via a constitutive coupling to Gs, driving cAMP signaling, and exhibits structural features typical of lipid-responsive GPCRs, including a dynamic hydrophobic tunnel[1][5]. No approved drugs target GPR3 clinically; however, inverse agonists and other tool compounds are under investigation as potential modulators for diseases such as Alzheimer’s disease[1][5].
Constitutive activation of Gs protein, leading to increased adenylate cyclase activity and cAMP production[1][3][5] Inverse agonists reduce basal activity by stabilizing the inactive receptor conformation[1]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor 3 (GPR3).